Dr Mark Smithers, the brains behind the Cavatax StoryAssoc Prof Mark Smithers Email: [email protected] Telephone: 07 3176 5306 Organisational Unit: Surgery
Topics: Melanoma. General surgery. Advanced endoscopic surgery. Upper GI surgery - notably oesophageal and gastric carcinoma.
Just a note for those who think that the "cancer is still in the boardroom and that cavatax is doomed". Revisit the ANN posted on 19/1, surely we have a drug at hand. A review of Melanon, indicates that it is one of the leading causes of death in Australia and significantly, at global level. The phase 1 trials were carried out on people who had not responded to normal therapies.The trial was succesful with all patients tolerating the treatment and none of them exhibiting any product related adverse side effects!
Next post tomorrow before 10am: Feedback from Prof Mark Smithers, the Chief Investigator, on current events and progress report
Happy trading!
VLA Price at posting:
63.0¢ Sentiment: Buy Disclosure: Held
